Privia Health Group, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
Privia Health Group, Inc. (PRVA) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $13.45 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-06
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $13.45M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $12.54M.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $12.54M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $10.00M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $13.45M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $12.54M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $12.54M 10-K · filed 2026-02-27 |
| 2025-09-30 | $10.00M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $9.59M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $6.69M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $6.69M 10-K · filed 2025-02-27 |
| 2024-09-30 | $5.86M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $5.86M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $5.86M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $6.02M 10-K · filed 2024-02-27 |
| 2023-09-30 | $6.17M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $5.13M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $5.15M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $3.34M 10-K · filed 2023-03-01 |
| 2022-09-30 | $3.34M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.34M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $3.29M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.29M 10-K · filed 2022-03-25 |
| 2021-09-30 | $643.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $643.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $643.00K 10-Q · filed 2021-05-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |